French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy
Alderaan Biotechnology has raised an €18.5M Series A round to push its lead cancer immunotherapy…
09/01/2020 - 2 minutes
Cancer
How BioNTech Navigates the Biotech Fundraising Maze
BioNTech is on a mission to individualize cancer therapy by developing a range of different…
18/12/2019 - 6 minutes
Cellestia Secures €18M to Develop First-in-Class Cancer Drug
Basel-based Cellestia Biotech has closed a €18M Series B financing round to help progress its…
18/12/2019 - 2 minutes
European Biotech: The Insider View
How has CRISPR changed drug development? How do you negotiate a good partnership? What are…
07/07/2019 - 10 minutes
This Company Automates Cancer Research from Bench to Bar Charts
In the academic city of Oxford, UK, the company Arctoris is working to make life…
11/01/2019 - 3 minutes
